ARCHIVED: NOT AVAILABLE FOR CREDIT
Updates in Pancreas
We will discuss the modifications to the AJCC Cancer Staging Manual 8th edition with regard to both the T and N categories of pancreatic adenocarcinoma, focusing on the reasons for changes and the practical implications. Furthermore, the slight alteration to the classification of neuroendocrine neoplasms in the AJCC Cancer Staging Manual 8th edition will be addressed, with an emphasis on how this impacts the clinical management and prognosis. We will conclude with a brief conversation of various pancreatic cysts and recent suggestions on the best classification system.
Originally presented on February 8, 2018, in Park City, Utah.
Lecture Presenter
Kajsa Affolter, MD Assistant Professor of Pathology |
Dr. Affolter is an assistant professor of pathology at the University of Utah School of Medicine. She received her MD from the University of Kansas School of Medicine while completing her residency in anatomic and clinical pathology and fellowship in gastrointestinal, hepatic, and pancreaticobiliary pathology at the University of Utah School of Medicine. She is certified by the American Board of Pathology in anatomic and clinical pathology and is a member of the United States and Canadian Academy of Pathology, American Society for Clinical Pathology, College of American Pathologists, and the Gastrointestinal Pathology Society, among other professional organizations. Dr. Affolter has research interests that include the serrated pathway of colorectal carcinogenesis and predictive markers in inflammatory bowel disease.
Objectives
After this presentation, participants will be able to:
- Explain the 8th edition AJCC Cancer Staging Manual modifications to appropriately stage pancreatic adenocarcinoma
- Differentiate the spectrum of diagnostic entities surrounding neuroendocrine neoplasms of the pancreas and understand why an additional category has been included in the 8th edition AJCC Cancer Staging Manual
- Describe routine cystic lesion of the pancreas, including both neoplastic malignant precursor lesions and non-neoplastic lesions
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories